Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MEK1 Antikörper (C-Term)

Es sind 2+ Publikationen für dieses Produkt verfügbar. Der Polyklonal anti-MEK1 Antikörper wird verwendet zum Nachweis von MEK1 in Proben von Human und Ratte. Er wurde validiert für WB, IHC (p) und ICC.
Produktnummer ABIN966512
-15% Promotion 2026
350,62 €
412,50 €
Sparen Sie 61,88 € (-15 %)
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 8 bis 11 Werktagen

Kurzübersicht für MEK1 Antikörper (C-Term) (ABIN966512)

Target

Alle MEK1 (MAP2K1) Antikörper anzeigen
MEK1 (MAP2K1) (Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1))

Reaktivität

  • 373
  • 208
  • 201
  • 44
  • 38
  • 19
  • 13
  • 12
  • 12
  • 9
  • 7
  • 5
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
Human, Ratte

Wirt

Bitte anfragen

Klonalität

  • 271
  • 107
Polyklonal

Konjugat

  • 178
  • 22
  • 14
  • 14
  • 13
  • 12
  • 11
  • 11
  • 11
  • 11
  • 8
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 2
  • 2
Dieser MEK1 Antikörper ist unkonjugiert

Applikation

  • 261
  • 129
  • 111
  • 70
  • 68
  • 66
  • 60
  • 48
  • 45
  • 39
  • 15
  • 9
  • 8
  • 7
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC)
  • Bindungsspezifität

    • 51
    • 30
    • 26
    • 24
    • 22
    • 19
    • 17
    • 16
    • 15
    • 14
    • 10
    • 10
    • 10
    • 8
    • 8
    • 8
    • 6
    • 6
    • 5
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 353-367, C-Term

    Immunogen

    A synthetic peptide corresponding to a sequence at the C-terminal of human MAP2K1 (353-367aa), identical to the related mouse and rat sequence.
  • Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Rekonstitution

    0.2ml of distilled water will yield a concentration of 500µg/ml.

    Buffer

    Each vial contains 5mg BSA, 0.9mg NaCl, 0.2mg Na2HPO4

    Konservierungsmittel

    Thimerosal (Merthiolate), Sodium azide

    Lagerung

    -20 °C
  • Rampoldi, Zimbello, Bortoluzzi, Tiso, Valle, Lanfranchi, Danieli: "Chromosomal localization of four MAPK signaling cascade genes: MEK1, MEK3, MEK4 and MEKK5." in: Cytogenetics and cell genetics, Vol. 78, Issue 3-4, pp. 301-3, (1998) (PubMed).

    Zheng, Guan: "Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2." in: The Journal of biological chemistry, Vol. 268, Issue 15, pp. 11435-9, (1993) (PubMed).

  • Target

    MEK1 (MAP2K1) (Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1))

    Andere Bezeichnung

    MAP2K1

    Hintergrund

    Dual specificity mitogen-activated protein kinase kinase 1 is an enzyme that in humans is encoded by the MAP2K1 gene. The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon activation by a wide variety of extra- and intracellular signals. As an essential component of the MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. Rampoldi et al. (1997) localized the MAP2K1 gene to 15q22.1-q22.33.

    Pathways

    MAPK Signalweg, RTK Signalweg, Interferon-gamma Pathway, Fc-epsilon Rezeptor Signalübertragung, Neurotrophin Signalübertragung, Activation of Innate immune Response, Toll-Like Receptors Cascades, Autophagie, Signaling of Hepatocyte Growth Factor Receptor, BCR Signaling
Sie sind hier:
Chat with us!